We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Affymetrix and Leica Microsystems Announce Worldwide Collaboration
News

Affymetrix and Leica Microsystems Announce Worldwide Collaboration

Affymetrix and Leica Microsystems Announce Worldwide Collaboration
News

Affymetrix and Leica Microsystems Announce Worldwide Collaboration

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Affymetrix and Leica Microsystems Announce Worldwide Collaboration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

This partnership provides researchers with a powerful automated everyday solution for drug-discovery, translational research, and the development of new companion diagnostic tests for personalized medicine by significantly reducing assay time for single-copy RNA in situ hybridization (ISH) analysis.

The highly-sensitive QuantiGene® ViewRNA ISH Tissue Assay assists drug discovery and translation research by enabling researchers to measure RNA expression directly in a tissue section at single-copy sensitivity. Over one thousand standard probes are already available and it only takes a few days to produce a customized probe for a new gene target. The Leica BOND RX system automates the staining process bringing all the benefits of consistency, reduced labor, and speed. This means researchers can now have access to same-day assay completion and, with a standardized staining protocol, rapid set-up for any probe.

George Bers, Vice President and General Manager of Expression Business Unit - Panomics at Affymetrix states that: “We are excited by this partnership with Leica as it unlocks the true potential of single-copy RNA analysis and we believe it will accelerate the discovery of important new drugs and the validation of novel companion tests.”

Arnd Kaldowski, President of Leica Biosystems, agrees saying “While medical science has created powerful new treatments that greatly enhance lives, there are still many disease states where we need to discover better treatments, or even cures. We are proud that this collaboration with Affymetrix can help in the discovery and development process by enabling researchers to reduce both the time and cost of research so that new treatments can be made available to patients sooner.”

Affymetrix’ QuantiGene® ViewRNA ISH Tissue Assay will be available for research applications in Q3 2012 on the research-optimized Leica BOND RX platform. An optimized QuantiGene® ViewRNA staining protocol will be pre-loaded onto the Leica BOND RX and a complete staining kit, including probes and all detection components, will be available from Affymetrix.

Advertisement